BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis

NCT02137226 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

645

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: BI 695501
DRUG: US-licensed Humira®

Sponsor

Boehringer Ingelheim